{
    "nctId": "NCT02725658",
    "briefTitle": "Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI",
    "officialTitle": "Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Concentration of oxy-hemoglobin (HbO2), in blood.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females between the ages of 21 and 80. Specific to Study part #1\n* Diagnosed with a Breast Imaging-Reporting and Data System score of 4 or higher breast abnormality greater than 1cm in size Specific to Study part #2\n* Enrolled in study part #1\n* Diagnosed with histologically-proven invasive breast cancer\n* Prescribed neoadjuvant chemotherapy for breast cancer\n\nExclusion Criteria:\n\n* Pregnant\n* Unable to give written, informed consent.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}